|
Double phase transfer of gold nanorods for surface functionalization and entrapment into PEG-based nanocarriers
|
journal
|
January 2009 |
|
Pemetrexed: biochemical and cellular pharmacology, mechanisms, and clinical applications
|
journal
|
February 2007 |
|
A Defect in the p53 Response Pathway Induced by de Novo Purine Synthesis Inhibition
|
journal
|
December 2003 |
|
Mechanisms of Membrane Transport of Folates into Cells and Across Epithelia
|
journal
|
August 2011 |
|
Tetrahydrofolate Recognition by the Mitochondrial Folate Transporter
|
journal
|
September 2011 |
|
PHENIX: a comprehensive Python-based system for macromolecular structure solution
|
journal
|
January 2010 |
|
The Antifolates
|
journal
|
June 2012 |
|
SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression
|
journal
|
February 2022 |
|
Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins
|
journal
|
June 1998 |
|
Therapeutic Targeting of a Novel 6-Substituted Pyrrolo [2,3-d]pyrimidine Thienoyl Antifolate to Human Solid Tumors Based on Selective Uptake by the Proton-Coupled Folate Transporter
|
journal
|
September 2011 |
|
The folate receptor as a rational therapeutic target for personalized cancer treatment
|
journal
|
October 2014 |
|
Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition
|
journal
|
August 2013 |
|
NRF2 regulates serine biosynthesis in non–small cell lung cancer
|
journal
|
October 2015 |
|
Exploiting the folate receptor α in oncology
|
journal
|
March 2020 |
|
Human reduced folate carrier: translation of basic biology to cancer etiology and therapy
|
journal
|
March 2007 |
|
The Major Facilitative Folate Transporters Solute Carrier 19A1 and Solute Carrier 46A1: Biology and Role in Antifolate Chemotherapy of Cancer
|
journal
|
January 2014 |
|
Targeting Tumour Proliferation with a Small-Molecule Inhibitor of AICAR Transformylase Homodimerization
|
journal
|
July 2012 |
|
Targeting the Proton-Coupled Folate Transporter for Selective Delivery of 6-Substituted Pyrrolo[2,3-d]Pyrimidine Antifolate Inhibitors of De Novo Purine Biosynthesis in the Chemotherapy of Solid Tumors
|
journal
|
July 2010 |
|
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
|
journal
|
January 2016 |
|
The molecular determinants of de novo nucleotide biosynthesis in cancer cells
|
journal
|
February 2009 |
|
Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker
|
journal
|
September 2016 |
|
Metabolic Profiling Reveals a Dependency of Human Metastatic Breast Cancer on Mitochondrial Serine and One-Carbon Unit Metabolism
|
journal
|
January 2020 |
|
Induction of serine hydroxymethyltransferase 2 promotes tumorigenesis and metastasis in neuroblastoma
|
journal
|
January 2022 |
|
Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma
|
journal
|
October 2017 |
|
A systematic analysis of atomic protein–ligand interactions in the PDB
|
journal
|
January 2017 |
|
Benzo[f]quinazoline Inhibitors of Thymidylate Synthase: Methyleneamino-Linked Aroylglutamate Derivatives
|
journal
|
March 1994 |
|
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
|
Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design
|
journal
|
April 2011 |
|
XDS
|
journal
|
January 2010 |
|
One-carbon metabolism in cancer
|
journal
|
May 2017 |
|
Fluorescence ratio imaging microscopy: temporal and spatial measurements of cytoplasmic pH
|
journal
|
April 1987 |
|
How good are my data and what is the resolution?
|
journal
|
June 2013 |
|
Synthesis and Biological Activity of a Novel Series of 6-Substituted Thieno[2,3-d]pyrimidine Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors over the Reduced Folate Carrier and Proton-Coupled Folate Transporter for Cellular Entry†
|
journal
|
April 2009 |
|
Synthesis and Antitumor Activity of a Novel Series of 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitors of Purine Biosynthesis with Selectivity for High Affinity Folate Receptors and the Proton-Coupled Folate Transporter over the Reduced Folate Carrier for Cellular Entry
|
journal
|
January 2010 |
|
Overexpression of SHMT2 Predicts a Poor Prognosis and Promotes Tumor Cell Growth in Bladder Cancer
|
journal
|
June 2021 |
|
Synthesis, Biological, and Antitumor Activity of a Highly Potent 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Antifolate Inhibitor with Proton-Coupled Folate Transporter and Folate Receptor Selectivity over the Reduced Folate Carrier That Inhibits β-Glycinamide Ribonucleotide Formyltransferase
|
journal
|
September 2011 |
|
The proton-coupled folate transporter: physiological and pharmacological roles
|
journal
|
December 2013 |
|
One-Pot Synthesis of Unsymmetrical N-Heterocyclic Carbene Ligands fromN-(2-Iodoethyl)arylamine Salts
|
journal
|
August 2009 |
|
Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy
|
journal
|
April 2004 |
|
Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment
|
journal
|
July 2022 |
|
Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade
|
journal
|
May 2015 |
|
Isolation and partial characterization of three methotrexate-resistant phenotypes from Chinese hamster ovary cells
|
journal
|
May 1976 |
|
Discovery of N-(6-Fluoro-1-oxo-1,2-dihydroisoquinolin-7-yl)-5-[(3R)-3-hydroxypyrrolidin-1-yl]thiophene-2-sulfonamide (LSN 3213128), a Potent and Selective Nonclassical Antifolate Aminoimidazole-4-carboxamide Ribonucleotide Formyltransferase (AICARFT) Inhibitor Effective at Tumor Suppression in a Cancer Xenograft Model
|
journal
|
November 2017 |
|
Multi-target pharmacology: possibilities and limitations of the “skeleton key approach” from a medicinal chemist perspective
|
journal
|
September 2015 |
|
Room‐Temperature Practical Copper‐Catalyzed Amination of Aryl Iodides
|
journal
|
March 2016 |
|
Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
|
journal
|
December 2021 |
|
Synthesis and Discovery of High Affinity Folate Receptor-Specific Glycinamide Ribonucleotide Formyltransferase Inhibitors with Antitumor Activity
|
journal
|
August 2008 |
|
Reversal of Cytosolic One-Carbon Flux Compensates for Loss of the Mitochondrial Folate Pathway
|
journal
|
June 2016 |
|
Cellular Pharmacodynamics of a Novel Pyrrolo[3,2- d ]pyrimidine Inhibitor Targeting Mitochondrial and Cytosolic One-Carbon Metabolism
|
journal
|
November 2019 |
|
One-Carbon Metabolism in Health and Disease
|
journal
|
January 2017 |
|
Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential
|
journal
|
March 2021 |
|
Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
|
journal
|
August 2016 |
|
Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors
|
journal
|
May 2021 |
|
Overexpression of mitochondrial serine hydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas
|
journal
|
January 2017 |
|
Novel Pyrrolo[3,2-d]pyrimidine Compounds Target Mitochondrial and Cytosolic One-carbon Metabolism with Broad-spectrum Antitumor Efficacy
|
journal
|
October 2019 |
|
Design, Synthesis, and Biological Evaluation of Classical and Nonclassical 2-Amino-4-oxo-5-substituted-6-methylpyrrolo[3,2-d]pyrimidines as Dual Thymidylate Synthase and Dihydrofolate Reductase Inhibitors
|
journal
|
December 2007 |
|
New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
|
journal
|
August 2018 |
|
Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase
|
journal
|
August 2016 |
|
Nucleophile recognition as an alternative inhibition mode for benzoic acid based carbonic anhydrase inhibitors
|
journal
|
January 2012 |
|
Measurement of cytosolic and mitochondrial pH in living cells during reversible metabolic inhibition
|
journal
|
January 2008 |
|
Metabolic enzyme expression highlights a key role for MTHFD2 and the mitochondrial folate pathway in cancer
|
journal
|
January 2014 |
|
Sequential alcohol oxidation/putative homo Claisen–Tishchenko-type reaction to give esters: a key process in accessing novel biologically active lactone macrocycles
|
journal
|
January 2016 |
|
Developing multi-target therapeutics to fine-tune the evolutionary dynamics of the cancer ecosystem
|
journal
|
September 2015 |
|
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor‐selective drug delivery, low therapeutic efficacy and unsustainable costs
|
journal
|
March 2018 |
|
Folate Receptor β Is Expressed by Tumor-Associated Macrophages and Constitutes a Marker for M2 Anti-inflammatory/Regulatory Macrophages
|
journal
|
December 2009 |
|
Targeting tumors that lack methylthioadenosine phosphorylase (MTAP) activity: Current strategies
|
journal
|
April 2011 |
|
Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia
|
journal
|
September 2014 |
|
Fluorine-Substituted Pyrrolo[2,3-d]Pyrimidine Analogues with Tumor Targeting via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis
|
journal
|
April 2018 |
|
Combination therapy in combating cancer
|
journal
|
March 2017 |
|
Structural basis of inhibition of the human serine hydroxymethyltransferase SHMT 2 by antifolate drugs
|
journal
|
June 2019 |
|
Immortalization with telomerase of the Nestin-positive cells of the human pancreas
|
journal
|
February 2003 |
|
Serine hydroxymethyltransferase 2 (SHMT2) potentiates the aggressive process of oral squamous cell carcinoma by binding to interleukin enhancer-binding factor 2 (ILF2)
|
journal
|
March 2022 |
|
The human proton-coupled folate transporter
|
journal
|
December 2012 |
|
Functional Loss of the Reduced Folate Carrier Enhances the Antitumor Activities of Novel Antifolates with Selective Uptake by the Proton-Coupled Folate Transporter
|
journal
|
June 2012 |
|
6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors
|
journal
|
August 2015 |
|
Crystal Structures of Human Bifunctional Enzyme Aminoimidazole-4-carboxamide Ribonucleotide Transformylase/IMP Cyclohydrolase in Complex with Potent Sulfonyl-containing Antifolates
|
journal
|
April 2004 |
|
Isolation of Human cDNAs That Restore Methotrexate Sensitivity and Reduced Folate Carrier Activity in Methotrexate Transport-defective Chinese Hamster Ovary Cells
|
journal
|
July 1995 |
|
Therapeutic Targeting of Mitochondrial One-Carbon Metabolism in Cancer
|
journal
|
November 2020 |
|
The mTORC1 Signaling Network Senses Changes in Cellular Purine Nucleotide Levels
|
journal
|
October 2017 |
|
Cyclic GMP-AMP Containing Mixed Phosphodiester Linkages Is An Endogenous High-Affinity Ligand for STING
|
journal
|
July 2013 |
|
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
|
journal
|
December 2013 |
|
The mitochondrial one‑carbon metabolic pathway is associated with patient survival in pancreatic cancer
|
journal
|
May 2018 |